ilyas sahin, MD ✓

@ilyassahinMD · Boston, MA · joined 30 Nov 2011

Assistant Professor @HarvardMed | GI Medical Oncologist @MassGeneralNews | Liver & GI Cancers | Clinical Trials

26 941Followers

410Following

14 936Posts total

2.5MViews on collected posts

Ultimi post

ilyas sahin, MD ✓@ilyassahinMD9 Sep

Good news for lung cancer🫁 The FDA just granted accelerated approval to sevabertinib (Hyrnuo) as a first-line treatment for a specific type of advanced lung cancer: non-squamous NSCLC with an activating HER2 (ERBB2) mutation. Until now, this targeted pill was approved only 475 views · 8 likes · 1 reposts · 0 replies Open on X →

ilyas sahin, MD ✓@ilyassahinMD9 Sep

A simple potential cancer-prevention measure: let very hot drinks cool a bit. In a prospective analysis of nearly 1 million UK adults, preferring tea or coffee "hot" or "very hot" was associated with ~ 1.7 and 3.2 times the risk of esophageal squamous-cell carcinoma, https://t.c

1.8K views · 32 likes · 1 reposts · 2 replies Open on X →

ilyas sahin, MD ✓@ilyassahinMD8 Sep

@ilyassahinMD Hope belongs in medicine, but so does rigor. These topline results sound promising, especially if T-cell engagement can move earlier in care. Now patients deserve the complete survival, safety, and quality-of-life data. Urgency and evidence must move together. #Lung 48 views · 0 likes · 0 reposts · 0 replies Open on X →

ilyas sahin, MD ✓@ilyassahinMD8 Sep

* https://t.co/6wbm4nXovj 391 views · 4 likes · 0 reposts · 0 replies Open on X →

ilyas sahin, MD ✓@ilyassahinMD8 Sep

Potentially practice-changing phase III news in extensive-stage small cell lung cancer. * In DeLLphi-305, adding the DLL3xCD3 T-cell engager tarlatamab to durvalumab maintenance after platinum/etoposide + durvalumab significantly improved overall survival and progression-free ht

2.1K views · 43 likes · 3 reposts · 2 replies Open on X →

ilyas sahin, MD ✓@ilyassahinMD8 Sep

The closer you look at biology, the more extraordinary it becomes. I still find myself coming back to this. 🌿 https://t.co/chLNgALkul

2:18

1.2K views · 22 likes · 3 reposts · 0 replies Open on X →

ilyas sahin, MD ✓@ilyassahinMD17 Aug

@ilyassahinMD Absolutely yes. The more you study DNA, the more astounded beyond words you become. Blows me away. I can't even look at plants and grass and trees now without just being in awe. 9.4K views · 528 likes · 14 reposts · 5 replies Open on X →

ilyas sahin, MD ✓@ilyassahinMD17 Aug

@ilyassahinMD @SCRIBEMOON I provided transcription support for the genetics textbook “Human Malformations” and it made me realize what a miracle a normal human birth actually is. 7.4K views · 408 likes · 16 reposts · 8 replies Open on X →

ilyas sahin, MD ✓@ilyassahinMD17 Aug

@ilyassahinMD and yet… https://t.co/3pvgcu0fYp

18.5K views · 785 likes · 77 reposts · 31 replies Open on X →

ilyas sahin, MD ✓@ilyassahinMD16 Aug

The complexity inside a single human cell is almost impossible to comprehend… https://t.co/lQ79LPuE4z

0:30

2.5M views · 9.4K likes · 1.9K reposts · 398 replies Open on X →

Rispetto ad account della stessa dimensione

10 post degli ultimi 90 giorni, accanto alla fascia di 10K–100K follower. arriva ben oltre il proprio pubblico, e quel pubblico reagisce.

Visualizzazioni mediane1 957questo account972mediana per 10K–100K

Copertura, %7.26%questo account3.58%mediana per 10K–100K

Interazione, %2.04%questo account1.60%mediana per 10K–100K

Metrica	Questo account	Mediana per 10K–100K	Rapporto
Visualizzazioni mediane per post	1 957	972	2.01×
Copertura (visualizzazioni ÷ follower)	7.26%	3.58%	2.03×
Tasso di interazione	2.04%	1.60%	1.27×

Altri account di questa fascia → Confronta con un altro account → Come sono costruiti questi parametri →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

2.5M16 Aug

18.5K17 Aug

7.4K

9.4K

1.2K8 Sep

2.1K

391

1.8K9 Sep

475

Last 10 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.49%16 Aug

4.84%17 Aug

5.86%

5.82%

2.16%8 Sep

2.30%

1.02%

0.00%

1.92%9 Sep

1.89%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.60%.

What the audience does

Likes63.3%11 256 in total

Reposts11.5%2 049 in total

Replies2.5%446 in total

Quotes1.8%324 in total

Bookmarks20.9%3 717 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Ultimi post

Rispetto ad account della stessa dimensione

Growth & engagement

Views per post

Engagement rate per post

What the audience does

Account simili